Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Financing › Details

Biocartis–SEVERAL: investment, 201611 private placement €32.7m of 4.06m new shares at €8.05/share

 

Period Period 2016-11-17
  Predecessor Biocartis–SEVERAL: investment, 201504 IPO €100m+€15m at Euronext Brussels 8.7m+1.3m new shares at €11.5/share
  Successor Biocartis–SEVERAL: investment, 201711 private placement €80m of 6.4m new shares at €12.5/share
Organisation Money taker Biocartis Group N.V. (Euronext Brussels: BCART)
  Group Biocartis (Group)
Products Product Idylla™ molecular diagnostics system
  Product 2 investment banking
Document Source Reuters. (11/17/16). "News: BRIEF – Biocartis Group Raises 32.7 Million Euros in Equity Placement".
     

   
Record changed: 2017-12-12

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Biocartis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top